Arthneeti
All Q2 FY26 results →
V(

Venkys (India) Ltd

Q2 FY26Food Products

Venkys (India) Q2 FY26 earnings call: Revenue & Margins

Q2 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹1,507
Market cap₹2.2K Cr
P/E12.4
Updated23 Aug 2026
Read4 min read

The short version

Animal Health segment is expected to grow steadily, aiming to cross INR 370-380 crores this year with new product lines planned, indicating stable and consistent growth. Poultry segment losses are significant currently but improvement expected in second half of FY '26 due to better realizations and demand post-festive season.

From Venkys (India) Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Animal Health segment is expected to grow steadily, aiming to cross INR 370-380 crores this year with new product lines planned, indicating stable and consistent growth.
  • Poultry segment volume utilization currently at 67% (broiler) and 75% (layer), with capacity available to increase production by about 25-33% if demand improves.
  • Expansion plans are underway for the SPF segment post-rainy season and possible layer segment expansion in FY 27-28, indicating future capacity increase.
  • Poultry prices expected to improve from January to June, supporting volume and revenue growth.

2 more points from Venkys (India) Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Venkys (India) Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Expansion plans underway in the SPF (Specific Pathogen Free) segment, with capacity buildup expected to start after the rainy season.
  • Capacity expansion has already taken place in the Animal Health Products (AHP) segment.
  • Plans for poultry segment expansion, particularly in the layer segment, are being considered for fiscal years 2027-28.

2 more points from Venkys (India) Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Food Products

Ranked on what management guided this quarter

Guidance-ranked
1Nurture Well Industries
Rev 1Mar 1
2Hoac Foods
Rev 1Mar 1
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Venkys (India) Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript does not explicitly mention the current or expected order book or pending orders details. However, from the management comments on capacity utilization and demand outlook: - Broiler segment utilization is at 67%, with room to increase by about one-third if demand arises. - Layer segment is at 75% utilization, with potential to utilize remaining capacity especially during the January to July season. - SPF segment utilization is at 50%, with capacity left if good orders are received. - Feed mill capacity utilization is 52%, and oilseed segment capacity utilization is around 50-55%. - Management expects an improved demand scenario from October last week onwards and hopes for better realization and packing production.

2 more points from Venkys (India) Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Venkys (India) Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹101 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Venky's (India)'s management said in earlier quarters

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Venkys (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Venkys (India) Ltd Q2 FY26 results?

Animal Health segment is expected to grow steadily, aiming to cross INR 370-380 crores this year with new product lines planned, indicating stable and consistent growth. Poultry segment losses are significant currently but improvement expected in second half of FY '26 due to better realizations and demand post-festive season.

What is Venkys (India) Ltd share price analysis?

Venkys (India) Ltd currently shows a neutral. The stock trades at a P/E of 12.4 with a market cap of ₹2,153 Cr. Investors should review the full earnings analysis for detailed insights.

Is Venkys (India) Ltd planning capital expenditure?

Expansion plans underway in the SPF (Specific Pathogen Free) segment, with capacity buildup expected to start after the rainy season.

Keep Venkys (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.